This WHO Centre’s website serves as an information platform. We are thus pleased to provide studies and documents of interest from other institutions in this field.
Carone, G., Schwierz, C., Xavier, A.: Cost-containment policies in public pharmaceutical spending in the EU. September; Economic Papers 461. European Commission, Directorate-General for Economic and Financial Affairs (Ed.)
Executive Agency of Health and Consumers (EAHC): EU Health Programme: working together to improve public health in Europe – A selection of Public Health Projects with an important impact for EU Member States”. In collaboration with the Health Programme’s National Focal Points (NFP) and the Directorate General for Health and Consumers (DG SANCO)
Kanavos, P., Schurer, W., Vogler, S.: The Pharmaceutical Distribution Chain in the European Union: Structure and Impact on Pharmaceutical Prices. March; Commissioned by the European Commission, Directorate-General Enterprise
Kanavos, P., Nicod, E., Espin, J., an den Aardweg, S. : Short- and Long-Term Effects of Value-Based Pricing vs. External Price Referencing. January; Commissioned by the European Commission, Directorate-General Enterprise
Espín, J., Rovira, J., García, L.: Experiences and Impact of European Risk-Sharing Schemes Focusing on Oncology Medicines. January; Commissioned by the European Commission, Directorate-General Enterprise
Kanavos, P., Seeley, L., Vandoros, S. Aardweg, S. : Tender systems for outpatient pharmaceuticals in the European Union: Evidence from the Netherlands, Germany and Belgium. September; Commissioned by the European Commission, Directorate-General Enterprise
OECD Health Policy Studies: Pharmaceutical Pricing Policies in a Global Market. September; Commissioned by the Organisation for Economic Co-operation and Development
Espín, J., Rovira, J.: Analysis of differences and commonalities in pricing and reimbursement systems in Europe. June; Andalusian School of Public Health; Commissioned by the European Commission, Directorate-General Enterprise